Gareth Morgan is Senior Vice President and Head of Global Portfolio Management for Shionogi. In addition to leading the Portfolio Management team, Gareth is responsible for providing strategic and policy direction related to anti-infective agents, and frequently represents Shionogi on anti-infective related government affairs and policy assignments, particularly those associated with the growing threat of antimicrobial resistance. Gareth has more than 25 years of experience with pharmaceutical and biotech companies, including BMS, Bayer, Genentech (now Roche) and Hoechst-Roussel (now Sanofi). He has led or provided functional and strategic oversight to development programs across multiple geographies and therapeutic areas.